ASX News
Immutep reports strong response rate from immunotherapies treating carcinomas
Immutep Ltd has reported a slew of positive results from a trial to assess a combination of immunotherapy cancer drugs.
RCU
0.00%
4.3¢
4.3¢
REAL ESTATE CAPITAL PARTNERS USA PROPERTY TRUST
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| RCU | Ann: Change of name and ASX code-RCU.AX | 24/10/16 | 0 | 1.2K | |||
|
|||||||
| RCU | Ann: Appendix 4G-RCU.AX | 30/09/16 | 0 | 449 | |||
|
|||||||
| RCU | Ann: Annual Report 2016-RCU.AX | 30/09/16 | 0 | 484 | |||
|
|||||||
| RCU | Ann: Appendix 3X-RCU.AX | 21/09/16 | 0 | 452 | |||
|
|||||||
| RCU | Ann: Director Appointment/Resignation-RCU.AX | 21/09/16 | 0 | 469 | |||
|
|||||||
| RCU | Ann: Becoming a substantial holder-RCU.AX | 08/09/16 | 0 | 446 | |||
|
|||||||
| RCU | Ann: Change in substantial holding-RCU.AX | 06/09/16 | 0 | 403 | |||
|
|||||||
| RCU | Ann: Appendix 4E and Financial Report 2016-RCU.AX | 31/08/16 | 0 | 425 | |||
|
|||||||
See All Discussions
